Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination

J Eur Acad Dermatol Venereol. 2022 Feb;36(2):e91-e93. doi: 10.1111/jdv.17736. Epub 2021 Oct 31.

Authors

E Panou¹, V Nikolaou¹, L Marinos², S Kallambou¹, P Sidiropoulou¹, M Gerochristou¹, A Stratigos¹

Affiliations

¹ 1st Dermatology Department, Andreas Syggros Hospital for Skin Diseases, National & Kapodestrian University of Athens Medical Schoool, Athens, Greece.
² Department of Hemopathology, Evangelismos Hospital, Athens, Greece.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
Lymphoma, T-Cell, Cutaneous*
SARS-CoV-2
Skin Neoplasms*
Vaccination

Substances

COVID-19 Vaccines